MARKET

VSTM

VSTM

Verastem
NASDAQ
7.43
0.00
0.00%
After Hours: 7.41 -0.02 -0.27% 17:44 05/02 EDT
OPEN
7.48
PREV CLOSE
7.43
HIGH
7.61
LOW
7.32
VOLUME
575.93K
TURNOVER
--
52 WEEK HIGH
13.52
52 WEEK LOW
2.100
MARKET CAP
382.57M
P/E (TTM)
-2.0312
1D
5D
1M
3M
1Y
5Y
1D
Verastem participates in a conference call with Cantor Fitzgerald
TipRanks · 3d ago
Verastem Oncology to Present at Upcoming Investor Conferences
Barchart · 3d ago
Weekly Report: what happened at VSTM last week (0421-0425)?
Weekly Report · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Colgate-Palmolive, Avantor, GE Healthcare
Reuters · 04/25 14:49
BUZZ-Verastem Oncology rises after $75 million private placement
Reuters · 04/25 14:00
Verastem Announces $75M Private Placement Agreement
TipRanks · 04/25 13:48
Verastem Oncology rises on $75M private placement
Seeking Alpha · 04/25 13:04
Verastem Oncology Announces $75M Private Placement
Benzinga · 04/25 13:01
More
About VSTM
More
Verastem, Inc. is a late-stage development biopharmaceutical company, which focuses on the development and commercialization of new medicines to improve the lives of patients diagnosed with ras sarcoma (RAS)/ mitogen-activated pathway kinase (MAPK) pathway-driven cancers. Its product candidates include avutometinib and defactinib. Avutometinib is an oral RAF/MEK clamp that inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with A-Raf proto-oncogene, potentially serine/threonine kinase (ARAF), B-Raf proto-oncogene serine/threonine kinase (BRAF) and C-raf proto-oncogene serine/threonine kinase, creating antitumor response through maximal RAS/MAPK pathway inhibition. Defactinib is an oral, selective inhibitor of FAK and proline-rich tyrosine kinase (PYK2), the two members of the focal adhesion kinase family of non-receptor protein tyrosine kinases. FAK and PYK2 integrate signals from integrin and growth factor receptors to regulate cell proliferation.
Recently
Symbol
Price
%Change

Webull offers Verastem Inc stock information, including NASDAQ: VSTM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VSTM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VSTM stock methods without spending real money on the virtual paper trading platform.